A 10-year-old male patient affected by type 2 von Willebrand disease (VWD)
and his family members were investigated by hemostatic and molecular geneti
c studies. The propositus, who experienced frequent bleeding episodes, was
characterized by a normal level of von Willebrand factor (VWF) antigen (54%
), reduced vWF ristocetin cofactor activity (5%), decreased factor VIII clo
tting activity (25%) and absent high molecular weight multimers in the plas
ma. An exon 28 fragment coding for the A1 and A2 domains was amplified by p
olymerase chain reaction and sequenced, We found a heterozygous mutation (G
4022A), producing an additional Pstl restriction site, which resulted in th
e substitution of Arg578Gln, Family studies, including the parents and a br
other, were negative for this mutation and vWF abnormalities were not obser
ved. We confirmed that G to A mutation in the region of the platelet glycop
rotein Ib binding domain of VWF causes the qualitative type 2 defect in von
Willebrand disease.